NCT04145271View on ClinicalTrials.gov

Pre-Hospital Zone 1 Partial Resuscitative Endovascular Balloon Occlusion of the Aorta for Injured Patients With Exsanguinating Sub-diaphragmatic Haemorrhage

CompletedOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

June 27, 2020

Primary Completion Date

March 31, 2022

Study Completion Date

March 31, 2022

Conditions
EmergenciesTrauma InjuryTrauma, Multiple
Interventions
DEVICE

Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA)

Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) is a minimally invasive damage control procedure for life-threatening abdominal and/or pelvic haemorrhage. It involves temporary occlusion of the aorta with an endovascular balloon, providing proximal control to the site of vascular injury whilst supporting cerebral and myocardial perfusion

Trial Locations (4)

E1 1FR

Royal London Hospital, London

E1

London HEMS, London

SW17 0QT

St. Georges Hospital, London

W2 1NY

St.Marys Hospital, London

All Listed Sponsors
lead

Barts & The London NHS Trust

OTHER

NCT04145271 - Pre-Hospital Zone 1 Partial Resuscitative Endovascular Balloon Occlusion of the Aorta for Injured Patients With Exsanguinating Sub-diaphragmatic Haemorrhage | Biotech Hunter | Biotech Hunter